Huakang Biomedical Holdings Co Ltd
HKEX:8622
Relative Value
The Relative Value of one Huakang Biomedical Holdings Co Ltd stock under the Base Case scenario is hidden HKD. Compared to the current market price of 0.375 HKD, Huakang Biomedical Holdings Co Ltd is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
Competitors Multiples
Huakang Biomedical Holdings Co Ltd Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| HK |
H
|
Huakang Biomedical Holdings Co Ltd
HKEX:8622
|
187.7m HKD | 6.5 | -35.2 | -26.2 | -26.2 | |
| US |
M
|
Medline Inc
NASDAQ:MDLN
|
58.5B USD | 0 | 0 | 0 | 0 | |
| JP |
|
Hoya Corp
TSE:7741
|
8.9T JPY | 9.8 | 35.7 | 25.7 | 30.9 | |
| CH |
|
Alcon AG
SIX:ALC
|
30.3B CHF | 3.8 | 36.9 | 15.3 | 29.7 | |
| DK |
|
Coloplast A/S
CSE:COLO B
|
111.8B DKK | 4 | 30.8 | 14.4 | 17.1 | |
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
12.7B USD | 3.2 | 33.6 | 15.3 | 19.4 | |
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
4.7B GBP | 2.7 | 29.2 | 13 | 21.1 | |
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
42.8B CNY | 9.4 | 26 | 23.5 | 23.5 | |
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
5.9B USD | 1.2 | -19.1 | 19.2 | 90.7 | |
| CH |
|
Ypsomed Holding AG
SIX:YPSN
|
4B CHF | 5 | 20.3 | 13.2 | 17.9 | |
| KR |
H
|
HLB Inc
KOSDAQ:028300
|
6.9T KRW | 85 | -31.2 | -72.3 | -68.4 |